Euglycemic Infusion of Insulin Detemir Compared With Human Insulin Appears to Increase Direct Current Brain Potential Response and Reduces Food Intake While Inducing Similar Systemic Effects

OBJECTIVE: In the treatment of diabetic patients, the long-acting insulin analog insulin detemir is less prone to induce weight gain than other insulin formulations. Assuming that because of its pharmacologic properties, detemir displays stronger central nervous anorexigenic efficacy than human insu...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Hallschmid, Manfred, Jauch-Chara, Kamila, Korn, Oliver, Mölle, Matthias, Rasch, Björn, Born, Jan, Schultes, Bernd, Kern, Werner
Format: Artigo
Idioma:Inglês
Publicat: American Diabetes Association 2010
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2844819/
https://ncbi.nlm.nih.gov/pubmed/20068139
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/db09-1493
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars